17 August 2021:
7:00-11:00 (Mexico City) | 8:00-12:00 (New York) | 9:00-13:00 (Brasilia)
18 August 2021:
7:00-12:00 (Mexico City) | 8:00-13:00 (New York) | 9:00-14:00 (Brasilia)
Ethics and business integrity are at the heart of patient-centered healthcare. As demonstrated by the COVID-19 pandemic, ethics and business integrity in health is also key to resilient and sustainable economic growth. As societies across the Americas continue their response to and recovery from the pandemic, leading government, industry, and civil society stakeholders will join together on 17 and 18 August 2021 for a virtual event focused on reinforcing ethics and business integrity across the Western Hemisphere’s health systems.
The Americas Health Ethics Virtual Forum, hosted live from Brasília, will showcase the advances in ethics and business integrity, transparency, and good governance that have been made since the 8th Summit of the Americas hosted by Peru in 2018. The Forum will catalyze significant progress in preparation for the 9th Summit of the Americas to be hosted by the United States in 2021 or 2022.
Marcelo Pacheco dos Guaranys, Executive Secretary, Ministry of Economy, Brazil
Introduced by:
Carlos Gouvea, Executive President, Brazilian Chamber of Laboratory Diagnostics (CBDL) & Intl Affairs, Health Ethics Institute (IES)
Bruno Boldrin Bezerra, Executive Director, ABRAIDI & President, ABIIS, Brazil
Consensus frameworks are groundbreaking convening mechanisms for national health stakeholders to routinely dialogue and align on ethical practices as well as help build mutual capacity where necessary. They recognize the benefits of co-created solutions to complex ethical dilemmas before gaps lead to problems for the health system or erode trust between stakeholders. Brazil becomes the ninth country in the world to formalize a consensus framework, joining Australia, Canada, Chile, China, Japan, Peru, the Philippines, and Vietnam.
Special Remarks
Marcelo Queiroga, Minister of Health, Brazil
Introduced by Eduardo Winston, President of the Board of Directors, Health Ethics Institute (IES)
The COVID-19 pandemic has underscored the importance of effective and ethical interactions between healthcare regulators and private health enterprises. Never before have we seen such a strong mutual need for these stakeholders to work together to bring health products and services to patients who need them while simultaneously upholding public trust through integrity in every interaction. What have we learned from the pandemic that can help us strengthen regulator-industry interactions throughout the region? Are there best practices that countries can adopt to achieve both effectiveness and integrity?
Panel of Government and Industry Leaders
Alex Machado Campos, Director, National Health Regulatory Agency (ANVISA), Brazil
Lucía Ayala Rodrígues, Technical Director, Medical Devices & Other Technologies National Food and Drug Surveillance Institute (Invima), Colombia
Miriam J. Loera Rosales, Director of International Relations, Federal Commission for the Protection against Sanitary Rick (COFEPRIS), Mexico
Katherine Serrano, Regional Director for Latin America,
U.S. Food and Drug Administration (FDA)
Nancy Travis, Vice President, Global Compliance and Governance, AdvaMed
Moderator: Sandra Ligia González, Executive Secretary, Inter-American Coalition for Regulatory Convergence for the Medical Technology Sector
The public sector serves an important role in purchasing health products and services for patients. This purchasing power represents an opportunity to elevate standards of ethical conduct by any enterprise or individual seeking to participate. What are the risks for patients of unethical conduct in health procurement? What have we learned during the pandemic about the role of ethics and business integrity in procurement in health-related sectors? What more can be done by procurement authorities at the international, national, and local level to ensure firms and individuals adhere to ethical practices in daily operations?
Panel of Government and Industry Leaders
Valentín Díaz Gracia, National Director, The Supply Center of the National Health Services System (Cenabast), Ministry of Health, Chile
Antonio Carlos Fonseca Silva, Deputy Attorney General of the Republic, Brazil & Member of the Board of Ethics, Health Ethics Institute (IES)
Rafael Andrés Díaz-Granados, Executive Director, Latin American Federation of the Pharmaceutical Industry (FIFARMA)
Moderator: Kathleen Hamann, Partner, Pierce Atwood LLP
Signing Ceremony: Fundação Getulio Vargas (FGV) and the International Anti-Corruption Academy (IACA)
One of Brazil’s leading higher education institutions and think tanks with a mission to stimulate the country’s socioeconomic development and the world's only international organization with a mandate focused solely on fighting corruption through education, research, cooperation, and technical assistance delivery will launch a partnership in a joint effort to foster integrity across the next generation of Brazilian public and private sector leaders.
Signing and Brief Remarks
Carlos Ivan Simonsen Leal, President, FGV
Ligia Maura-Costa, Coordinator, FGV Ethics
Thomas Stelzer, Dean and Executive Secretary, IACA
Opening Remarks
Mauricio Claver-Carone, President, Inter-American Development Bank
Introduced by Nacho Abia, President & CEO, Olympus Corporation of the Americas
& Board of Directors, The Advanced Medical Technology Association (AdvaMed)
Discussion on IDB Technical Cooperation to Promote Codes of Ethics
Roberto de Michele, Principal Specialist, Modernization of the State, IDB (TBC)
Oscar Caipo, President, La Confederación Nacional de Instituciones Empresariales Privadas (CONFIEP), Peru & Co-Chair, Transparency and Regulatory Working Group, Americas Business Dialogue
The Basel Institute on Governance, one of the world’s leading non-profit organizations dedicated to preventing and combating corruption and strengthening standards of governance, will share insights on the role of collective action initiatives in fostering integrity across health sectors. As the world recovers from the COVID-19 pandemic, the Basel Institute will also share thoughts on consensus frameworks for ethical collaboration and extend a special announcement. The Mexican Foundation for Health (Funsalud) will also share observations on the importance of collective action initiatives and the opportunity to launch a Mexican Consensus Framework for Ethical Collaboration.
Special Remarks
Gemma Aiolfi, Head of Compliance, Corporate Governance, and Collective Action, Basel Institute on Governance, Switzerland
Héctor Valle Mesto, Executive President, Mexican Foundation for Health (Funsalud)
Introduced by Karen Eryou, Chief of Staff, Enterprise Risk and International Markets Legal, Ethics & Compliance, UCB Pharma & Chair, IGO Working Group, Ethics and Business Integrity Committee, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
While the Americas is rightly focused on response and recovery from the COVID-19 pandemic and its related challenges, there are rapidly emerging ethical dilemmas confronting the region’s health systems in patient data and health technologies. We will hear from industry leaders who are on the front line of these dilemmas, working to help ensure trust is maintained while advancing health invention and innovation.
Emerging Ethical Dilemmas in Patient Data: Spotlight on Genomic Data
Phil Febbo, Senior Vice President & Chief Medical Officer, Illumina
Emerging Ethical Dilemmas in Health Technologies: Spotlight on Artificial Intelligence
Julien Durand, Chief Ethics and Compliance Officer, Sanofi & Chair, Future Health Technologies Working Group, Ethics and Business Integrity Committee, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) & Global Expert on Digital Health and Artificial Intelligence, World Health Organization
Patients are the only “why” in healthcare. They are the common bond that drives every ethical organization and individual who works in healthcare. Patient voices are on the frontlines working in collaboration with the public and private sector to address emerging ethical dilemmas, including those related to health data sharing and privacy. We will hear from international and national patient organization leaders and other stakeholders on this topic and identify emerging best practices to help ensure integrity.
Virtual Roundtable
Gonzalo Tobar Carrizo, President, Chilean Alliance of Patient Groups
Karla Ruiz de Castilla, Executive Director, ESPERANTRA, Peru
María Mercedes Rueda Gutiérrez, President, Fundare Bogotá, Colombia
Kawaldip Sehmi, Chief Executive Officer, International Alliance of Patient Organizations (IAPO)
Moderator: Russell Williams, Vice President, Diabetes Canada
Health providers, payors, and investors from both the public and private sectors serve an integral role in the functioning of every health system and in how patients access the care they need. As a result, these entities serve a fundamental role in the prevention of corruption in health systems. We will hear from international and national leaders on emerging ethical principles for health providers, payors, and investors and learnings from the pandemic to bolster integrity.
Virtual Roundtable
Chris McCahan, Chief Investment Officer and Global Sector Lead (Health), International Finance Corporation (IFC), World Bank Group
Bruno Sobral de Carvalho, Executive Secretary, National Health Confederation (CNSaúde), Brazil
Moderator: Rady Johnson, Exec. Vice President and Chief Compliance, Quality and Risk Officer, Pfizer & Chair, Ethics and Business Integrity Committee, IFPMA
Healthcare professionals are the trusted voice of patient care. Whether in the hospital or clinic, at the pharmacy counter, or even over our electronic devices, they are the few who millions of patients turn to each day across the Americas. They are also on the frontline of fighting the COVID-19 pandemic and understand firsthand the importance of a resilient health system. In addition to patients, many healthcare professionals interact with diverse stakeholders to enable or support their activities. Ensuring these interactions do not interfere with the independent judgements these healthcare professionals make for their patients is fundamental to upholding patient trust. As health systems undergo dramatic changes from new product and process innovations, the preservation of patient trust remains paramount. International and national healthcare professional leaders will share their perspectives on these topics and learnings from the pandemic to bolster integrity.
Virtual Roundtable
Jose Luiz Gomes do Amaral, President, São Paulo Association of Medicine, Brazil
Jeff Blackmer, Executive Vice President, Global Health & Chief Medical Officer,
Canadian Medical Association (CMA)
David Barbe, President, World Medical Association (WMA)
Moderator: Sujata Dayal, Vice President and Global Chief Compliance Officer, Medline Industries & Chair, Chief Compliance Officers Committee, AdvaMed
Innovative Solutions to Strengthening Ethical Third-Party Intermediary Relationships for the Medical Technology Sector
Special Remarks
Hugo Alberto von Ancken, Regional Sector Lead – Latin America, Health Care Compliance, Johnson & Johnson Medical Device Companies
Presentation on the Global Distributors Compliance Toolkit
Nancy Travis, Vice President, Global Compliance and Governance, AdvaMed
Brief Observations from MedTech Distributor and Manufacturer Associations
Bruno Boldrin Bezerra, Executive Director, ABRAIDI & President, ABIIS, Brazil
Victoria del Castillo, Executive Director, CADIEM, Argentina
Ana Riquelme, Executive Director, AMID, Mexico
Driving Regional Growth through Ethics, Transparency, and Good Governance
& Looking Ahead to the 9th Summit of the Americas
Ian Saunders, Deputy Assistant Secretary for the Western Hemisphere, U.S. Department of Commerce
Note: Introduction by Lynn Costa, Senior Advisor, Office of the Western Hemisphere, U.S. Department of Commerce.
Parting Words by Carlos Gouvea, Executive President, Brazilian Chamber of Laboratory Diagnostics (CBDL) & Intl Affairs, Health Ethics Institute (IES)
Chief Ethics and Compliance Officer, Sanofi
Chair, Future Health Technologies Working Group, Ethics and Business Integrity Committee, International Federation of Pharmaceutical Manufacturersand Associations (IFPMA) & Global Expert on Digital Health and Artificial Intelligence, World Health Organization
The United States will host the 9th Summit of the Americas, which is administered by the Organization of American States. The Summit is held roughly every three years. Peru convened the 8th Summit of the Americas in 2018, where ethics, transparency, and good governance were key priorities. The Lima Commitment “Democratic Governance Against Corruption” was issued at the 8th Summit.
The Americas Business Dialogue, housed within the Inter-American Development Bank, simultaneously launched during the 8th Summit the ABD Action for Growth Policy Recommendations, including strengthening transparency and integrity, and the Inter-American Coalition for Business Ethics in the MedTech Sector.
The Americas Health Ethics Virtual Forum on 17-18 August 2021 will assess the progress made to further ethical conduct, transparency, and good governance related to the Lima Commitment and ABD Action for Growth Policy Recommendations. The Forum will also galvanize additional progress in advance of the 9th Summit of the Americas.
Dr. John-Arne Røttingen, is the Ambassador for Global Health in Norway’s Ministry of Foreign Affairs and adjunct professor at the Department of Global Health and Population at Harvard T.H. Chan School of Public Health. Prior to his role in the Ministry of Foreign Affairs, he was the chief executive of the Research Council of Norway. Dr. Røttingen also served as the founding interim CEO of CEPI (Coalition for Epidemic Preparedness Innovations) and executive director of Infection Control and Environmental Health at the Norwegian Institute of Public Health. He is associate fellow at the Centre on Global Health Security, Chatham House, and member of the WHO Euro Advisory Committee on Health Research.
Dr. Jane Ruth Aceng is the Minister of Health in Uganda and a pediatrician by training. Dr. Aceng is also a member of the board of directors of the Infectious Diseases Institute at Makerere University, Uganda. Prior to becoming the Minister of Health, Dr. Aceng was the Director of General Health Services, promoting community health with this national platform. Her involvement in high-level meetings, advocacy, and technical conventions have demonstrated Uganda’s continued commitment to primary health care.
Betsy McKay is a senior writer for The Wall Street Journal. She writes about U.S. and global public health. Previously, she was Atlanta bureau chief, managing a team of reporters covering the Eastern U.S. and several industries. McKay is a member of the team of Journal reporters awarded the 1999 Pulitzer Prize in the international reporting category for in-depth analytical coverage of the Russian financial crisis. She has won awards for stories on public health issues, including drug-resistant tuberculosis and maternity care in the rural U.S. McKay holds a B.A. from Amherst College and an M.A. in Russian language and literature from Bryn Mawr College.
Dr. Sylvain Aldighieri currently serves as Deputy Director of the Pan American Health Organization (PAHO). He specializes in Epidemiology and Tropical Microbiology. Prior to joining PAHO, Dr. Aldighieri worked across Africa and the Americas as a Medical Officer for the French Government and World Health Organization. He was previously the coordinator of PAHO’s International Health Regulations, Alert and Response and Epidemic Diseases Unit.
Annette Msabeni-Ngoye is the Deputy Secretary General of the Kenya Red Cross. She was previously the Head of Program Operations and Development at the Agency for Cooperation and Research in Development in Kenya, helping support the country offices across Africa to conduct assessments in Ebola, floods, drought, and conflict emergencies and to develop and implement emergency response and resilience strengthening interventions. Earlier in her career, Msanbeni-Ngoye focused on HIV and AIDs with both Kenya Red Cross and Medecins Sans Frontieres.
